Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-min Luo

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Molecular Medicine Reports|January 15, 2013
Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cellsShu-Qiang Wu, Ya-Er Lv, Bai-Hua Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2010
Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP modelJian Zhu, Zi-Cheng Zhang, Bao-Sheng Li, et al.
Cancer Cell International|March 3, 2016
Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinomaXin-Rui Liu, Cui-Xia Cai, Li-Min Luo, et al.
Biomaterials|November 7, 2012
Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelLi-Min Luo, Yue Huang, Bing-Xiang Zhao, et al.
International Journal of Nanomedicine|July 26, 2013
The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationKe-Fu Yu, Wei-Qiang Zhang, Li-Min Luo, et al.
Journal of Drug Targeting|June 20, 2015
Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?Wei-Qiang Zhang, Ke-Fu Yu, Ting Zhong, et al.
Virology Journal|May 19, 2025
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot studyLi-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Molecular Medicine Reports|January 15, 2013
Silencing of periostin inhibits nicotine-mediated tumor cell growth and epithelial-mesenchymal transition in lung cancer cellsShu-Qiang Wu, Ya-Er Lv, Bai-Hua Lin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 12, 2010
Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP modelJian Zhu, Zi-Cheng Zhang, Bao-Sheng Li, et al.
Cancer Cell International|March 3, 2016
Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinomaXin-Rui Liu, Cui-Xia Cai, Li-Min Luo, et al.
Biomaterials|November 7, 2012
Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxelLi-Min Luo, Yue Huang, Bing-Xiang Zhao, et al.
International Journal of Nanomedicine|July 26, 2013
The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluationKe-Fu Yu, Wei-Qiang Zhang, Li-Min Luo, et al.
Journal of Drug Targeting|June 20, 2015
Does ligand-receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?Wei-Qiang Zhang, Ke-Fu Yu, Ting Zhong, et al.
Virology Journal|May 19, 2025
Recurrence risk factors for chronic hepatitis B virus-infected patients who achieve functional cure with pegylated interferon-α-2b-based therapy: a multicenter pilot studyLi-Jun Chang, Chun-Qiu Hao, Gui-Rong Rao, et al.
Pageof 4